Association Between Homocysteine and All-Cause Mortality Among Osteoarthritis Patients: A Cohort Study from the NHANES Database
Hormone and Metabolic Research · 01.02.2025 · 57 (02) · 134-143
DOI: 10.1055/a-2460-7718 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.02.2025. Verfasst von Yu Shi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China. Hauptthemen laut MEDLINE: Homocysteine, Osteoarthritis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
This study explored the association between serum Hcy level and the all-cause mortality among osteoarthritis (OA) patients. This cohort study included patients diagnosed as OA from the National Health and Nutrition Examination Survey (NHANES) 1999–2006. Abbott Homocysteine assay, a fully automated fluorescence polarization immunoassay (FPIA) method, was used to measure the level of serum Hcy. Covariates included sociodemographic information, lifestyles, history of diseases and medications were extracted from the database. The weighted univariate, multivariate Cox proportional hazard models and restricted cubic splines (RCS) were utilized to explore the association between Hcy level and all-cause mortality in OA patients, with hazard ratios (HRs) and 95% confidence intervals (CIs). Subgroup analyses based on different age, gender, duration of OA, complications and C-reactive protein (CRP) were further assessed by this association. Totally 1384 OA patients were included in this study, of which 817 (59.03%) died by 31 December 2019. After adjusting all covariates, high Hcy level was associated with the high all-cause mortality among OA patients (HR=1.31, 95%CI: 1.02–1.67), especially in females (HR=1.43, 95%CI: 1.07–1.91), aged >60 years (HR=1.49, 95%CI: 1.14–1.94), duration of OA >10 years (HR=1.40, 95%CI: 1.01–1.95), with the history of hypertension (HR=1.37, 95%CI: 1.03–1.80), without the history of diabetes (HR=1.36, 95%CI: 1.01–1.82) or CRP >0.29 mg/l (HR=1.51, 95%CI: 1.04–2.19). High serum Hcy level was associated with high risk of all-cause mortality in OA patients. Our results suggest that serum Hcy is a promising biomarker for the prognosis of OA patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
ORCID-Profile: Lu Lu
Zitieren
APA
Shi, Y., Lu, M., He, F., Chen, J., Zheng, C., & Lu, L. (2025). Association Between Homocysteine and All-Cause Mortality Among Osteoarthritis Patients: A Cohort Study from the NHANES Database. Hormone and Metabolic Research, 57(02), 134-143. https://doi.org/10.1055/a-2460-7718
Vancouver
Shi Y, Lu M, He F, Chen J, Zheng C, Lu L. Association Between Homocysteine and All-Cause Mortality Among Osteoarthritis Patients: A Cohort Study from the NHANES Database. Hormone and Metabolic Research. 2025;57(02):134-143. doi:10.1055/a-2460-7718
BibTeX
@article{Shi2025,
author = {Shi, Yu and Lu, Minan and He, Feng and Chen, Jinzhong and Zheng, Chuanchuan and Lu, Lu},
title = {Association Between Homocysteine and All-Cause Mortality Among Osteoarthritis Patients: A Cohort Study from the NHANES Database},
journal = {Hormone and Metabolic Research},
year = {2025},
volume = {57},
number = {02},
pages = {134--143},
doi = {10.1055/a-2460-7718}
}
EUVIMED